{"Symbol": "ACOG", "AssetType": "Common Stock", "Name": "Alpha Cognition Inc", "Description": "Alpha Cognition Inc. is a biopharmaceutical innovator specializing in the development of breakthrough therapies for neurodegenerative conditions, particularly Alzheimer's disease. The company is advancing its flagship candidate, ACOG-100, which aims to enhance cognitive function in patients, thereby addressing critical unmet needs within the aging demographic. With a robust research and development focus and a proprietary platform that leverages cutting-edge neuroscience, Alpha Cognition is well-positioned to transform patient care in this sector. As it seeks to deliver meaningful clinical advances, the company presents compelling investment opportunities within the dynamic healthcare landscape.", "CIK": "1655923", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "750 WEST PENDER STREET, VANCOUVER, BC, CANADA, V6C 2T8", "OfficialSite": "https://www.alphacognition.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "106101000", "EBITDA": "-17278716", "PERatio": "None", "PEGRatio": "None", "BookValue": "2.087", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-1.38", "RevenuePerShareTTM": "0.5", "ProfitMargin": "-2.622", "OperatingMarginTTM": "-1.87", "ReturnOnAssetsTTM": "-0.422", "ReturnOnEquityTTM": "-1.256", "RevenueTTM": "7427200", "GrossProfitTTM": "5709100", "DilutedEPSTTM": "-1.38", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "20", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "1", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "26.88", "PriceToSalesRatioTTM": "14.29", "PriceToBookRatio": "3.129", "EVToRevenue": "7.87", "EVToEBITDA": "-1.572", "Beta": "2.598", "52WeekHigh": "11.54", "52WeekLow": "3.75", "50DayMovingAverage": "5.74", "200DayMovingAverage": "7.59", "SharesOutstanding": "21742100", "SharesFloat": "14996200", "PercentInsiders": "9.808", "PercentInstitutions": "38.327", "DividendDate": "None", "ExDividendDate": "None"}